ปัณณพัทธ์ โกษาแสง (@krapalm)

NEXCOM Highlights Dual 5G Security Solutions and ODM Expertise at Interop Tokyo 2025

Lockheed Martin Aims to Cultivate Filipino Talent, Stimulate Job Growth and Advance Local Defense Sector with Industrial Collaboration Proposal

JW Therapeutics Announces Approval of Relmacabtagene Autoleucel Injection (Carteyva®) for Marketing in Macao

Tiger Brokers Hong Kong Launches Inaugural Art Prize with HKBU AVA to Inspire Young Artists and Creative Crossovers

Akeso’s PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations–Third Approved Indication for Cadonilimab

FeelNeedy: Because Every Pet Deserves to Feel Loved

Seoul Releases Global Tourism Campaign Featuring Star Chef Edward Lee

POWERCHINA Advances Malaysia’s Clean Energy Goals on World Environment Day 2025

Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Renal Cell Carcinoma

Innovent’s IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Receives Second NMPA Breakthrough Therapy Designation for Immuno-resistant Squamous Non-Small Cell Lung Cancer

Proto Axiom and St Vincent’s Curran Foundation join forces to host Australia’s largest medical pitch day

Luckin Coffee Celebrates Its New Coconut & Jelly Latte and Limited-Edition Baby Coconut Keychains

ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy

การประชุม ERA Congress: ข้อมูลระยะยาวแสดงประสิทธิศักย์และความปลอดภัยอย่างต่อเนื่องของ zigakibart ในผู้ป่วยโรคไตอักเสบชนิด IgA